Pharma prices to remain relatively free in US - IHS Markit

In this segment, Milena Izmirlieva, Head of Life Sciences at IHS Markit talks to Tip TV’s Zak Mir about the implications of the Trump victory for the Pharmaceutical business in the US. Milena states it is too early to say if Trump would be good for Pharma Business and adds the prices are likely to remain relatively free in the US. While talking about China, she states there is little appetite in China to block the US Pharma products from entering into the Chinese borders.

#Trump, #Clinton, #Pharmaceuticals, #economy, #macro, #fundamentals